Innospec Inc. (NASDAQ:IOSP) Shares Bought by Citigroup Inc.

Citigroup Inc. raised its position in Innospec Inc. (NASDAQ:IOSP) by 46.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,193 shares of the specialty chemicals company’s stock after acquiring an additional 10,162 shares during the period. Citigroup Inc. owned approximately 0.13% of Innospec worth $3,641,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of IOSP. Inspire Advisors LLC lifted its stake in shares of Innospec by 1.6% during the second quarter. Inspire Advisors LLC now owns 6,819 shares of the specialty chemicals company’s stock worth $843,000 after buying an additional 110 shares during the period. Arizona State Retirement System lifted its stake in shares of Innospec by 1.9% during the second quarter. Arizona State Retirement System now owns 6,962 shares of the specialty chemicals company’s stock worth $860,000 after buying an additional 128 shares during the period. Texas Permanent School Fund Corp lifted its stake in shares of Innospec by 0.6% during the second quarter. Texas Permanent School Fund Corp now owns 21,891 shares of the specialty chemicals company’s stock worth $2,706,000 after buying an additional 129 shares during the period. Raymond James Trust N.A. lifted its stake in shares of Innospec by 7.9% during the third quarter. Raymond James Trust N.A. now owns 2,106 shares of the specialty chemicals company’s stock worth $238,000 after buying an additional 155 shares during the period. Finally, Evergreen Capital Management LLC lifted its stake in shares of Innospec by 8.6% during the second quarter. Evergreen Capital Management LLC now owns 2,421 shares of the specialty chemicals company’s stock worth $299,000 after buying an additional 192 shares during the period. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, StockNews.com downgraded shares of Innospec from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 8th.

Innospec Price Performance

NASDAQ IOSP opened at $118.97 on Thursday. The company has a market capitalization of $2.97 billion, a PE ratio of 20.76 and a beta of 1.09. The company has a fifty day moving average of $114.97 and a 200 day moving average of $118.08. Innospec Inc. has a 1 year low of $103.97 and a 1 year high of $133.71.

Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.35. The company had revenue of $443.40 million during the quarter, compared to the consensus estimate of $442.13 million. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The firm’s quarterly revenue was down 4.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.59 earnings per share. Research analysts expect that Innospec Inc. will post 5.88 earnings per share for the current year.

Innospec Increases Dividend

The firm also recently announced a Semi-Annual dividend, which was paid on Tuesday, November 26th. Investors of record on Monday, November 18th were given a dividend of $0.79 per share. The ex-dividend date of this dividend was Monday, November 18th. This is an increase from Innospec’s previous Semi-Annual dividend of $0.72. This represents a yield of 1.3%. Innospec’s payout ratio is currently 27.57%.

Insider Activity at Innospec

In other Innospec news, Director Milton C. Blackmore sold 1,035 shares of Innospec stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $122.92, for a total value of $127,222.20. Following the completion of the transaction, the director now owns 9,028 shares of the company’s stock, valued at approximately $1,109,721.76. The trade was a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.35% of the stock is currently owned by insiders.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.